Medication info
Risadryn Plus Tablet

Risadryn Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201605330 · Approved 2016.08.31 · Insurance code 652903880

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 1 tablet of this drug orally once weekly 2. Older adults: No dose adjustment is necessary, since the bioavailability and pharmacokinetics of this drug in older adults (60 years of age and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This drug is contraindicated in patients with severe renal impairment with a creatinine clearance of less than 30ml/min. Because food interferes with the absorption of this drug, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To help the drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking this drug. If patients do not get sufficient calcium and vitamin D from food, they should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this drug provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take this drug on the scheduled day, take it on the day they remember. Resume taking the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children: Safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men. Osteoporosis is a condition where the bone density decreases, increasing the risk of fractures. This medicine helps to strengthen bones and prevent fractures. Therefore, it is effective in improving bone health issues related to osteoporosis.

How to take

Adult dose

1. Adults: Administer 1 tablet of this drug orally once weekly 2. Older adults: No dose adjustment is necessary, since the bioavailability and pharmacokinetics of this drug in older adults (60 years of age and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This drug is contraindicated in patients with severe renal impairment with a creatinine clearance of less than 30ml/min. Because food interferes with the absorption of this drug, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To help the drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking this drug. If patients do not get sufficient calcium and vitamin D from food, they should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this drug provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take this drug on the scheduled day, take it on the day they remember. Resume taking the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children: Safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the mucosa of the stomach and esophagus, which can lead to conditions such as esophagitis, esophageal ulcer, and esophageal erosion. Therefore, if symptoms such as difficulty swallowing, chest pain, or heartburn occur during treatment, it is important to stop taking the medication immediately and consult a doctor. It is essential to take it with a sufficient amount of water and not to lie down for at least 30 minutes after taking it. This medication should not be used in patients with esophageal strictures or achalasia, hypocalcemia, or severe renal impairment. Additionally, patients with lactose intolerance should not take this medication. During treatment, side effects such as indigestion, abdominal pain, diarrhea, headache, muscle pain, joint pain, rash, and itching may occur, so inform a doctor about any abnormal symptoms. Rarely, jaw necrosis, serious skin reactions, or liver dysfunction may occur, and caution is necessary. The safety of this medication during pregnancy has not been established, so pregnant women should avoid taking it, and breastfeeding women should either discontinue medication or breastfeeding. Safety and efficacy have not been established for use in children. Elderly patients show similar safety to general adults, but caution is advised during treatment. In the case of overdose, symptoms of hypocalcemia may occur, so consult healthcare professionals immediately; calcium supplementation or gastric lavage may be necessary. This medication may interfere with the absorption of other medications containing calcium, magnesium, iron, aluminum, etc., so it should be taken with intervals from them. Always read the product leaflet and follow the doctor's instructions for proper dosing.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • decreased blood calcium
Show 97 more
  • decreased blood phosphorus
  • bone pain
  • joint pain
  • muscle pain
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • infection
  • back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • joint abnormalities
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • lightheadedness
  • tension increase
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • indigestion
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • dizziness
  • bronchitis
  • cough
  • edema
  • facial edema
  • hair loss
  • altered smell
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • jawbone necrosis
  • liver dysfunction
  • jaundice
  • external auditory canal osteonecrosis
  • loss of appetite
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture, maintaining a storage temperature between 1 to 30 degrees Celsius to ensure the effectiveness and safety of the medicine.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.